Description: This is the 508 compliant static HTML/CSS mock up of the Details View.
Documents: Please also view Details View Wireframe, Workflow Diagram [PDF, 464KB], and Use Scenario Case Documentation [PDF, 165KB] for full details on implementation.
00012345
60 for 30 days ( of 0 remaining)
40 mg PO QDAY
Provider, Fifteen
Provider, Fifteen
Primary Care
Abilene (CAA)
| Date | Supply | Delivery Method |
|---|---|---|
| 09/28/2014 | 180 for 90 days | Window |
| 03/28/2014 | 180 for 90 days | Window |
| 03/28/2013 | 180 for 90 days | Window |
00012345
60 for 30 days ( of 0 remaining)
40 mg PO QDAY
Provider, Fifteen
Provider, Fifteen
Primary Care
Abilene (CAA)
| Date | Supply | Delivery Method |
|---|---|---|
| 09/28/2014 | 180 for 90 days | Window |
| 03/28/2014 | 180 for 90 days | Window |
| 03/28/2013 | 180 for 90 days | Window |
00012345
60 for 30 days ( of 0 remaining)
40 mg PO QDAY
Provider, Fifteen
Provider, Fifteen
Primary Care
Abilene (CAA)
| Date | Supply | Delivery Method |
|---|---|---|
| 09/28/2014 | 180 for 90 days | Window |
| 03/28/2014 | 180 for 90 days | Window |
| 03/28/2013 | 180 for 90 days | Window |
05/04/2013 - 08:25
Glucose, Serum or Plasma Quantitative
H
100 mg/dL
70-99
Provider, Fifteen
Abilene (CAA)
| Date | Flag | Result | Ref Range | Facility |
|---|---|---|---|---|
| 05/04/2013 - 08:25 | H | 100 mg/dL | 70-99 | Abilene (CAA) |
| 04/09/2013 - 10:13 | 72 mg/dL | 70-99 | Abilene (CAA) | |
| 03/09/2013 - 09:23 | L* | 60 mg/dL | 70-99 | DOD |
| 02/03/2013 - 16:16 | 85 mg/dL | 70-99 | Abilene (CAA) | |
| 01/02/2013 - 11:51 | L* | 52 mg/dL | 70-99 | DOD |
| 12/02/2012 - 09:23 | 78 mg/dL | 70-99 | Abilene (CAA) | |
| 11/02/2012 - 08:22 | H | 100 mg/dL | 70-99 | Abilene (CAA) |
| 10/02/2012 - 08:22 | 76 mg/dL | 70-99 | DOD |
01/09/2014
Hep B - Adult
3
No
Provider, Fifteen
Abilene (CAA)
| Date | Summary | Reaction | Series | Repeat Contraindicated | Facility |
|---|---|---|---|---|---|
| 01/09/2014 | Hep B - Adult | Window | 3 | No | DOD |
| 12/03/2013 | Hep B - Adult | Window | 3 | No | DOD |
| 12/02/2013 | Hep B - Adult | Window | 3 | No | DOD |
| 11/18/2013 | Hep B - Adult | 3 | No | DOD | |
| 11/15/2013 | Hep B - Adult | 3 | No | DOD |
| Problems | Status | Problem Code | Problem Type | Date of Onset | Date Resolved | Cause of Death | Age of Onset |
|---|---|---|---|---|---|---|---|
| Benign Essential Hypertension | -- -- | 401.1 | -- -- | -- -- | -- -- | -- -- | -- -- |
| Coronary Artery Disease | -- -- | 414.00 | -- -- | -- -- | -- -- | -- -- | -- -- |
| Hyperlipidemia | -- -- | 272.4 | -- -- | -- -- | -- -- | -- -- | -- -- |
| Stroke Syndrome | -- -- | 436 | -- -- | -- -- | -- -- | -- -- | -- -- |
| Vascular Dementia | -- -- | 290.40 | -- -- | -- -- | -- -- | -- -- | -- -- |
| Gout | -- -- | 274.00 | -- -- | -- -- | -- -- | -- -- | -- -- |
| Atrial Fibrillation | -- -- | 427.31 | -- -- | -- -- | -- -- | -- -- | -- -- |
Hyperlipidemia Coronary Artery Disease Fatigue Benign Essential Hypertension Atrial Fibrillation Gout Vascular Dementia Stroke Syndrome Rosacea Memory Lapses Or Loss Normal Routine History And Physical Senior Citizen (65-80) Dysplastic Nevus
04/01/2004 - 22:57
Consult
Complete
Abilene (CAA)
| To Service | AUDIOLOGY OUTPATIENT |
|---|---|
| From Service | GENERAL MEDICINE |
| Requesting Provider | PATHOLOGY, ONE |
| Place | Consultant's choice |
| Urgency | Routine |
| Orderable Item | AUDIOLOGY OUTPATIENT |
| Procedure | Consult |
| Reason | 86 year old MALE referred for suspected hearing loss. |
| Local Title | AUDIOLOGY - HEARING LOSS CONSULT |
| Heading 1 | Heading 2 |
|---|---|
| Local Title | AAUDIOLOGY - HEARING LOSS CONSULTe |
| Date of Note | 04/01/2004 - 22:57 |
| Author | Pathology, One |
| Status | Completed |
HX: Patient was seen for hearing aid fitting and orientation. The batteries supplied for this hearing aid were: za312.
IMP: The veteran was seen for hearing aid fitting and orientation. A complete orientation was performed, and the patient can insert the aids(s), change the batteries, and adjust the volume. Response curves were obtained using a real-ear probe microphone in-situ Measurement System and indicated appropriate gain for the demonstrated hearing loss. Care of the aid(s), warranty information and dangers of battery ingestion were discussed with the veteran.
REC: Continued use of present amplification is recommended
| Date/Time | 04/01/2004 - 22:57 |
|---|---|
| Responsible | PATHOLOGY, ONE |
| Date/Time | 04/01/2004 - 22:58 |
|---|---|
| Responsible | PATHOLOGY, ONE |
| Drug Classes | PENICILLINS AND BETA-LACTAM ANTIMICROBIALS |
|---|---|
| Nature of Reaction | Adverse Reaction |
| Severity | |
| Entered By | VEHU,EIGHT |
| Originated | 03/17/2005 - 20:09 |
| Verified | 03/17/2005 - 20:09 |
| Observed/Historical | Consult |
| Observed Date | Historical |
| Site | CAMP MASTER |